Privia Health Group, Inc.

PRVA • Medical - Healthcare Information Services

$22.93

— 0.00 (0.00%)

ResultadosÚltimo reporte: 30 jun 2026

PERFIL EQUILIBRADONeutralConfianza: 70%

Perfil cuantitativo — no constituye una recomendación de inversión.

Perfil cuantitativo — no constituye una recomendación de inversión.Metodología

Tesis del análisis: Perfil mixto. La empresa no es necesariamente mala, pero la valoración, el crecimiento o el balance todavía no justifican una señal más fuerte.

Capitalización

$3.01B

Crecimiento

15.3%

Flujo de caja

5/5

Tendencia

Stable

Evidencia

Crecimiento positivo de ingresos · 18.0%Flujo de caja libre positivo · 1.33Flujo de caja libre consistente · 5/5Nivel de deuda manejable · 0.01Liquidez saludable · 1.6

Datos financieros hasta: 30 jun 2026, 12:00 a.m. UTCÚltima actualización de earnings: 30 jun 2026, 12:00 a.m. UTCÚltima actualización del perfil: 7 ago 2026, 12:56 p.m. UTC

Resumen de la compañía

Valoración, calidad, fortaleza financiera, momentum y datos de analistas.

Price$22.93

Change0.00%

Shares Out131.36M

Market Cap$3.01B

Enterprise Value$-400.46B

52W Range19.08 - 28.82

Beta0.84

P/E0.25

P/S0.00

P/B0.00

P/FCF-0.06

EV/Sales-0.32

Price$22.93

Change0.00%

Shares Out131.36M

Market Cap$3.01B

Enterprise Value$-400.46B

52W Range19.08 - 28.82

Beta0.84

P/E0.25

P/S0.00

P/B0.00

P/FCF-0.06

EV/Sales-0.32

EV/EBITDA-12.75

EV/FCF8.31

Earnings Yield402.66%

Dividend Yield0.00%

Gross Margin9.87%

Oper. Margin1.61%

Profit Margin1.08%

Debt/Eq0.01

Current Ratio1.60

Quick Ratio1.60

Revenue 5Y15.34%

FCF 5Y60.25%

Target$28.00

Target Upside22.11%

Target Median$28.00

Target Range24.00 - 32.00

Volume4.38M

Avg Volume1.15M

EPS Surprise-0.06

ADN de inversión

Qué tan fuerte luce esta compañía para inversionistas de largo plazo

de 100

Calidad del negocio

Márgenes, ventaja competitiva, retornos

40/100

Fortaleza financiera

Deuda, caja, estabilidad

73/100

Potencial de crecimiento

Ingresos y expansión

95/100

Atractivo del precio

Barata o cara hoy

56/100

Por qué este puntaje▼

Crecimiento positivo de ingresos · 18.0%Flujo de caja libre positivo · 1.33Flujo de caja libre consistente · 5/5Nivel de deuda manejable · 0.01Liquidez saludable · 1.6Múltiplo de ganancias caro · 126.39

Analyst view

Analyst sentiment and price target

PRVA

Analyst sentiment

Based on 22 analyst votes · 2026-10-20

95/100

Bullish

Hold

Bearish

Precio objetivo

2026-08-07

Bajo

$24.00

Promedio

$29.50

Mediana

$29.00

Alto

$36.00

Resumen de la compañía

IPO: 4/28/2021

Industria: Medical - Healthcare Information Services

P/B i: 0.00

Deuda / Patrimonio i: 0.01

Margen operativo: 1.61%

Margen neto: 1.08%

ROE i: -

ROIC: -

Salud financiera

Puntaje15 / 20

Deuda / Patrimonio: 0.01

Ratio corriente: 1.60

Ratio rápido: 1.60

Estado: Good

Transacciones internas

Actividad reciente de ejecutivos e insiders

Mountcastle David

Transacción: 07/09/2026

VENTA

Cambio

-21,275

Precio

$27.67

Presentación

07/13/2026

Tipo

VENTA

Mountcastle David

Transacción: 07/07/2026

VENTA

Cambio

-600

Precio

$27.57

Presentación

07/09/2026

Tipo

VENTA

Morris Matthew Shawn

Transacción: 07/06/2026

VENTA

Cambio

-53,722

Precio

$27.24

Presentación

07/07/2026

Tipo

VENTA

Insider	Tipo	Cambio	Precio	Transacción	Presentación
Mountcastle David	VENTA	-21,275	$27.67	07/09/2026	07/13/2026
Mountcastle David	VENTA	-600	$27.57	07/07/2026	07/09/2026
Morris Matthew Shawn	VENTA	-53,722	$27.24	07/06/2026	07/07/2026
Morris Matthew Shawn	VENTA	-53,722	$2.00	07/06/2026	07/07/2026
Mountcastle David	VENTA	-24,734	$27.50	07/02/2026	07/07/2026
Morris Matthew Shawn	VENTA	-59,037	$27.33	07/02/2026	07/07/2026
Morris Matthew Shawn	VENTA	-59,037	$2.00	07/02/2026	07/07/2026
Morris Matthew Shawn	VENTA	-37,041	$26.93	07/01/2026	07/02/2026
Morris Matthew Shawn	VENTA	-82,675	$2.00	07/01/2026	07/02/2026
Morris Matthew Shawn	VENTA	-52,823	$25.72	06/30/2026	07/02/2026
Morris Matthew Shawn	VENTA	-52,823	$2.00	06/30/2026	07/02/2026
Morris Matthew Shawn	VENTA	-63,212	$25.33	06/29/2026	06/30/2026
Morris Matthew Shawn	VENTA	-63,212	$2.00	06/29/2026	06/30/2026
Mountcastle David	VENTA	-8,897	$2.00	06/26/2026	06/30/2026
Mountcastle David	VENTA	-17,196	$25.18	06/26/2026	06/30/2026
Morris Matthew Shawn	COMPRA	+88,110	$2.00	06/26/2026	06/30/2026
Morris Matthew Shawn	VENTA	-88,110	$2.00	06/26/2026	06/30/2026
SOISTMAN FRANCIS S JR	OTRO	0	Not reported	05/20/2026	05/22/2026
KING DAVID P	COMPRA	+8,463	Not reported	05/20/2026	05/22/2026
Ryu Jaewon	COMPRA	+8,463	Not reported	05/20/2026	05/22/2026

Sobre la compañía

Privia Health Group, Inc.

Privia Health Group, Inc. functions as a national entity focused on empowering physicians throughout the United States. It partners with medical groups, health plans, and health systems, with the primary objective of optimizing physician practices, enhancing patient experiences, and appropriately compensating clinicians for care delivered both virtually and in person. To achieve this, Privia offers a comprehensive suite of services. These include technology and population health tools designed to streamline independent providers' workflows; a Management Services Organization (MSO) that alleviates administrative tasks, freeing providers to focus on clinical care; a single-TIN medical group, which bolsters payer negotiations, facilitates clinical integration, and aligns financial incentives; an Accountable Care Organization (ACO) designed to engage patients, reduce inefficient utilization, and improve care coordination and patient quality metrics, thereby advancing value-based care; and a network connecting providers with new patient populations and enabling custom contracts with purchasers and payers. Founded in 2007, the company's headquarters are located in Arlington, Virginia. Privia Health Group, Inc. was formerly a subsidiary of Brighton Health Group Holdings, LLC.

Fuente - Link

Competidores

ARQT ATEC HTFL ICUI LIVN NVST PBH PINC SUPN TVTX

Tamaño = capitalización · color = línea del gráfico

Rendimiento de peers · 1A

Top performers + empresa seleccionada

Ultimas Noticias

Privia Health to Report Third Quarter 2026 Results on Thursday, November 5

ARLINGTON, Va., Oct. 08, 2026 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced that it expects to release financial results for its third-quarter and nine-month periods ended September 30, 2026 before market open on Thursday, November 5, 2026.

GlobeNewsWire

Anthem Blue Cross and Blue Shield in Virginia and Privia Health Reach New Agreement

RICHMOND, Va.--(BUSINESS WIRE)--Anthem Blue Cross and Blue Shield in Virginia and Privia Health have reached a new agreement that will continue providing Anthem members with in-network access to Privia Medical Group physicians across Virginia.The agreement reflects a shared commitment to ensuring Virginians have access to high-quality healthcare while advancing value-based care and helping keep healthcare affordable.“Strong partnerships with physicians are essential to improving healthcare for t.

Business Wire

Reviewing Guardant Health (NASDAQ:GH) & Privia Health Group (NASDAQ:PRVA)

Privia Health Group (NASDAQ: PRVA - Get Free Report) and Guardant Health (NASDAQ: GH - Get Free Report) are both healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, profitability, earnings, analyst recommendations, institutional ownership, risk and valuation. Analyst Ratings This is a summary of

Defense World

Bank of New York Mellon Corp Purchases Shares of 2,892,536 Privia Health Group, Inc. $PRVA

Bank of New York Mellon Corp acquired a new stake in Privia Health Group, Inc. (NASDAQ: PRVA) in the quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 2,892,536 shares of the company's stock, valued at approximately $74,425,000. Bank of

Defense World

Deutsche Bank AG Makes New $6.02 Million Investment in Privia Health Group, Inc. $PRVA

Deutsche Bank AG purchased a new stake in shares of Privia Health Group, Inc. (NASDAQ: PRVA) in the second quarter, according to its most recent 13F filing with the SEC. The fund purchased 234,049 shares of the company's stock, valued at approximately $6,022,000. Deutsche Bank AG owned approximately 0.19% of Privia Health Group

Defense World

Sorpresas de ganancias

Período	Estimado	Real	Sorpresa
2026-05-07	0.08	0.02	-0.06
2026-02-26	0.04	0.07	0.03
2025-11-06	0.06	0.05	-0.01
2025-08-07	0.05	0.02	-0.03
2025-05-08	0.06	0.03	-0.03
2025-02-27	0.05	0.03	-0.02
2024-11-07	0.05	0.03	-0.02
2024-08-08	0.05	0.03	-0.02
2024-05-09	0.05	0.02	-0.03
2024-02-27	0.04231	0.02	-0.02231
2023-11-03	0.05	0.05	0
2023-08-03	0.06	0.06	0